Dancing with pharmaceutical industry – medical practice between ethics and business
Keywords:
health industries, relationship marketing for healthcare organizationsAbstract
The relation between physicians and the pharmaceutical companies has been increasingly discretted issue over the last several years.Moreover, such relations have been proven to influence the prescribing patterns to stimulate drug supplying within hospitals, to encourage publications and research articles and even to contribute to critical article non-publication.There is a complex relation between physicians, medical organizations and academic departments, on the one hand and industry on the other. Therefore, industry makes its living from the physicians prescriptions and from the devices and services they purchase.Yet physicians, medical organizations, and academic departments commonly receive money and other benefits from the industry.This paper reviews specialist literature and addresses the real dimension of the physician-health related industry worldwide interaction. Unfortunately, Romania has not provided any data yet, because this issue has not been officially analyzed in our country.References
· Pharmaceutical Research and Manufacturers of America, PhRMA code on interactions with healthcare professionals, 2004.
· American Medical Association, Updated clarification on opinion E-8.061: gifts to physicians from industry, 1998.
· Elliott C., Pharma goes to the laundry: public relations and the business of medical education, Hastings Cent Rep 34:18-23, 2004.
· Campbell, E. G., J. S. Weissman, S. Ehringhaus, S. R. Rao, B. Moy, S. Feibelmann, and S. D. Goold, Institutional academic industry relationships, JAMA 298 (15):1779-86, 2007.
· Chren, M. M., Interactions between physicians and drug company representatives, Am J Med 107 (2):182-3, 1999.
· Ehringhaus, S. H., J. S. Weissman, J. L. Sears, S. D. Goold, S. Feibelmann, and E. G. Campbell, Responses of medical schools to institutional conflicts of interest, JAMA 299 (6):665-71, 2008.
· Goldratt E, Cox J., The goal: a process of ongoing improvement, Edited by N. R. Press. Great Barrington, Massachusetts, 2004.
· Greene, J. A., Pharmaceutical marketing research and the prescribing physician, Ann Intern Med , 146 (10):742-8, 2007.
· Hayashi, J., Free meals from the pharmaceutical industry. JAMA 285 (2):164-5; author reply 165-6, 2001.
· Network., Pharma Marketing, Key opinion leader, 2004.
· Popp, R. J. et al., ACCF/AHA consensus conference report on professionalism and ethics, Circulation 110 (16):2506-49, 2004.
· Rothman, D. J., Academic medical centers and financial conflicts of interest, JAMA 299 (6):695-7, 2008.
· Rutledge P., Crookes D., McKinstry B., Maxwell SR. Do doctors rely on pharmaceutical industry funding to attend conferences and do they perceive that this creates a bias in their drug selection? Results from a questionnaire survey, Pharmacoepidemiol Drug Safety 12:663-667, 2003.
· Spingarn, R. W., J. A. Berlin, and B. L. Strom, When pharmaceutical manufacturers' employees present grand rounds, what do residents remember? Acad Med 71 (1):86-8, 1996.
· Steinbrook, R., Guidance for guidelines, N Engl J Med 356 (4):331-3, 2007.
· Steinman, M. A., L. A. Bero, M. M. Chren, and C. S. Landefeld, Narrative review: the promotion of gabapentin: an analysis of internal industry documents, Ann Intern Med 145 (4):284-93, 2006.
· Tonelli, M. R., Conflict of interest in clinical practice, Chest 132 (2):664-70, 2007.
· Wazana, A., Physicians and the pharmaceutical industry: is a gift ever just a gift? JAMA 283 (3):373-80, 2000.
